Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001498428-26-000004

CEO & President sold 4,986 shares at $26.28 ($131,032)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cox John · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-13 Sale : show line 1 in the form 10b5-1 −4,986 $26.28 $131,032 363,165 D
Open-market sales · 4,986 sh · avg $26.28 · $131,032
Loading xslF345X06/ownership.xml…